Department of Otolaryngology-Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Key Laboratory of Otolaryngology Major Disease Research of Hunan Province, Changsha, Hunan 410008, China; Center for Medical Genetics, Central South University, Changsha, Hunan 410008, China.
Department of Otolaryngology-Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Key Laboratory of Otolaryngology Major Disease Research of Hunan Province, Changsha, Hunan 410008, China; Center for Medical Genetics, Central South University, Changsha, Hunan 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Gene. 2019 Jul 1;704:113-120. doi: 10.1016/j.gene.2019.04.008. Epub 2019 Apr 8.
Usher syndrome (USH) is a clinically common autosomal recessive disorder characterized by retinitis pigmentosa (RP) and sensorineural hearing loss with or without vestibular dysfunction. In this study, we identified a Hunan family of Chinese descent with two affected members clinically diagnosed with Usher syndrome type 3 (USH3) displaying hearing, visual acuity, and olfactory decline. Whole-exome sequencing (WES) identified a nonsense variant in ABHD12 gene that was confirmed to be segregated in this family by Sanger sequencing and exhibited a recessive inheritance pattern. In this family, two patients carried homozygous variant in the ABHD12 (NM_015600: c.249C>G). Mutation of ABHD12, an enzyme that hydrolyzes an endocannabinoid lipid transmitter, caused incomplete PHARC syndrome, as demonstrated in previous reports. Therefore, we also conducted a summary based on variants in ABHD12 in PHARC patients, and in PHARC patients showing that there was no obvious correlation between the genotype and phenotype. We believe that this should be considered during the differential diagnosis of USH. Our findings predicted the potential function of this gene in the development of hearing and vision loss, particularly with regard to impaired signal transmission, and identified a novel nonsense variant to expand the variant spectrum in ABHD12.
乌谢尔综合征(USH)是一种常见的常染色体隐性遗传疾病,其特征为视网膜色素变性(RP)和感觉神经性听力损失,伴有或不伴有前庭功能障碍。在这项研究中,我们鉴定了一个湖南汉族家系,该家系中有两名临床诊断为乌谢尔综合征 3 型(USH3)的患者,表现为听力、视力和嗅觉下降。全外显子组测序(WES)发现 ABHD12 基因中的无义变异,经 Sanger 测序证实该变异在家系中呈共分离状态,表现为隐性遗传模式。在该家系中,两名患者均携带 ABHD12(NM_015600:c.249C>G)的纯合变异。先前的研究表明,ABHD12 是一种水解内源性大麻素脂质递质的酶,其突变导致不完全 PHARC 综合征。因此,我们还根据 PHARC 患者 ABHD12 中的变异以及表现出无明显基因型与表型相关性的 PHARC 患者的变异进行了总结。我们认为,在 USH 的鉴别诊断中应考虑这一点。我们的研究结果预测了该基因在听力和视力丧失发育中的潜在功能,特别是在信号转导受损方面,并鉴定了一个新的无义变异,扩展了 ABHD12 中的变异谱。